Maryo Kohen, MD
Specialty: Pediatric Ophthalmology
Maryo C. Kohen, MD, is a pediatric ophthalmologist and Adult Strabismus specialist for University Hospitals Rainbow Babies & Children’s Hospital and University Hospitals Cleveland Medical Center. He also serves as an Assistant Professor for the Case Western Reserve University School of Medicine Department of Ophthalmology & Visual Sciences.
Dr. Kohen attended The Istanbul University Cerrahpasa Faculty of Medicine where he earned his medical doctor degree. He completed his ophthalmology residency at Yeditepe University in Istanbul. He was a research fellow for two years at Case Western Reserve University, Department of Ophthalmology and Visual Sciences. He completed his pediatric ophthalmology and adult strabismus clinical fellowship at UH Cleveland Medical Center and UH Rainbow Babies & Children’s Hospital.
Dr. Kohen’s research focused on the drug eluding polymers for children after ophthalmic surgery. He was awarded research grants from Knights Templar Eye Foundation and Ohio Lions Eye Research Foundation. He serves as a clinical attending for medical students and residents in the areas of pediatric ophthalmology and strabismus.
Dr. Kohen’s practice focuses on routine and medical ocular examinations of children and adults with strabismus with a special interest in retinopathy of prematurity, management of amblyopia, pediatric ocular disease, and special needs children.
Aside from clinical practice, Dr. Kohen lectures at ophthalmology continuing education events, participates in clinical research, and attends local and national ophthalmology meetings to maintain a high quality evidence-based approach to his practice.
- Pediatric Ophthalmology
- Retinopathy of Prematurity (ROP)
Fellowship | Pediatric Ophthalmology
Pediatric Ophthalmology - UH Cleveland Medical Center (2018 - 2020)
Fellowship | Pediatric Ophthalmology
Pediatric Ophthalmology - UH Cleveland Medical Center (2017 - 2018)
Research Fellowship | Ophthalmology
Ophthalmology - UH Cleveland Medical Center (2014 - 2017)
Istanbul Universitesi Cerrahpasa Tip Fakultesi (2007)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Maryo Kohen did not disclose any Outside Relationships with Industry.